Literature DB >> 19243453

Neurodevelopmental delay in the Cln3Deltaex7/8 mouse model for Batten disease.

N S Osório1, B Sampaio-Marques, C-H Chan, P Oliveira, D A Pearce, N Sousa, F Rodrigues.   

Abstract

Juvenile neuronal ceroid lipofuscinosis (JNCL), also known as Batten disease, is a fatal inherited neurodegenerative disorder. The major clinical features of this disease are vision loss, seizures and progressive cognitive and motor decline starting in childhood. Mutations in CLN3 are known to cause the disease, allowing the generation of mouse models that are powerful tools for JNCL research. In this study, we applied behavioural phenotyping protocols to test for early behavioural alterations in Cln3(Deltaex7/8) knock-in mice, a genetic model that harbours the most common disease-causing CLN3 mutation. We found delayed acquisition of developmental milestones, including negative geotaxis, grasping, wire suspension time and postural reflex in both homozygous and heterozygous Cln3(Deltaex7/8) preweaning pups. To further investigate the consequences of this neurodevelopmental delay, we studied the behaviour of juvenile mice and found that homozygous and heterozygous Cln3(Deltaex7/8) knock-in mice also exhibit deficits in exploratory activity. Moreover, when analysing motor behaviour, we observed severe motor deficits in Cln3(Deltaex7/8) homozygous mice, but only a mild impairment in motor co-ordination and ambulatory gait in Cln3(Deltaex7/8) heterozygous animals. This study reveals previously overlooked behaviour deficits in neonate and young adult Cln3(Deltaex7/8) mice indicating neurodevelopmental delay as a putative novel component of JNCL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243453      PMCID: PMC3114406          DOI: 10.1111/j.1601-183X.2009.00478.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  30 in total

1.  [Ultrastructure of neuronal ceroid-lipofuscinoses].

Authors:  H H Goebel
Journal:  Fortschr Med       Date:  1977-10-27

2.  CT findings in neuronal ceroid lipofuscinoses.

Authors:  R Raininko; P Santavuori; H Heiskala; K Sainio; J Palo
Journal:  Neuropediatrics       Date:  1990-05       Impact factor: 1.947

3.  Electrophysiological findings of neuronal ceroid lipofuscinosis in heterozygotes.

Authors:  I Gottlob; K P Leipert; A Kohlschütter; H H Goebel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

4.  Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs).

Authors:  J M Holopainen; J Saarikoski; P K Kinnunen; I Järvelä
Journal:  Eur J Biochem       Date:  2001-11

Review 5.  Human forms of neuronal ceroid-lipofuscinosis (Batten disease): consensus on diagnostic criteria, Hamburg 1992.

Authors:  A Kohlschütter; R M Gardiner; H H Goebel
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).

Authors:  Gail M Seigel; Andrew Lotery; Ari Kummer; David J Bernard; Nicholas D E Greene; Mark Turmaine; Todd Derksen; Robert L Nussbaum; Beverly Davidson; Janet Wagner; Hannah M Mitchison
Journal:  Mol Cell Neurosci       Date:  2002-04       Impact factor: 4.314

7.  Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth.

Authors:  Susan L Cotman; Vladimir Vrbanac; Lori-Anne Lebel; Richard L Lee; Kevin A Johnson; Leah-Rae Donahue; Allison M Teed; Kristen Antonellis; Roderick T Bronson; Terry J Lerner; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

8.  Comparison of brain perfusion SPECT and MRI findings in children with neuronal ceroid-lipofuscinosis and in their families.

Authors:  Elvan Sayit; Ilginc Yorulmaz; Recep Bekis; Gamze Kaya; F Gul Gumuser; Eray Dirik; Hatice Durak
Journal:  Ann Nucl Med       Date:  2002-05       Impact factor: 2.668

9.  Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.

Authors:  Chun-Hung Chan; Hannah M Mitchison; David A Pearce
Journal:  Hum Mol Genet       Date:  2008-08-04       Impact factor: 6.150

10.  Neurobehavioral development of two mouse lines commonly used in transgenic studies.

Authors:  M Dierssen; V Fotaki; M Martínez de Lagrán; M Gratacós; M Arbonés; C Fillat; X Estivill
Journal:  Pharmacol Biochem Behav       Date:  2002-08       Impact factor: 3.533

View more
  12 in total

1.  Pharmacological Effects on Ceroid Lipofuscin and Neuronal Structure in Cln3 ∆ex7/8 Mouse Brain Cultures.

Authors:  Douglas E Brenneman; David A Pearce; Attila Kovacs; Shawn DeFrees
Journal:  J Mol Neurosci       Date:  2017-08-15       Impact factor: 3.444

2.  Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Δex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Rozzy Finn; Attila D Kovács; David A Pearce
Journal:  Neurochem Int       Date:  2011-02-17       Impact factor: 3.921

Review 3.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 4.  Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs).

Authors:  Nihar Kinarivala; Paul C Trippier
Journal:  J Med Chem       Date:  2015-11-24       Impact factor: 7.446

Review 5.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

6.  Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease.

Authors:  Jessica L Centa; Francine M Jodelka; Anthony J Hinrich; Tyler B Johnson; Joseph Ochaba; Michaela Jackson; Dominik M Duelli; Jill M Weimer; Frank Rigo; Michelle L Hastings
Journal:  Nat Med       Date:  2020-07-27       Impact factor: 53.440

7.  Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism.

Authors:  Michael J Kane; Mariana Angoa-Peréz; Denise I Briggs; Catherine E Sykes; Dina M Francescutti; David R Rosenberg; Donald M Kuhn
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

8.  Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system.

Authors:  John F Staropoli; Larissa Haliw; Sunita Biswas; Lillian Garrett; Sabine M Hölter; Lore Becker; Sergej Skosyrski; Patricia Da Silva-Buttkus; Julia Calzada-Wack; Frauke Neff; Birgit Rathkolb; Jan Rozman; Anja Schrewe; Thure Adler; Oliver Puk; Minxuan Sun; Jack Favor; Ildikó Racz; Raffi Bekeredjian; Dirk H Busch; Jochen Graw; Martin Klingenspor; Thomas Klopstock; Eckhard Wolf; Wolfgang Wurst; Andreas Zimmer; Edith Lopez; Hayat Harati; Eric Hill; Daniela S Krause; Jolene Guide; Ella Dragileva; Evan Gale; Vanessa C Wheeler; Rose-Mary Boustany; Diane E Brown; Sylvie Breton; Klaus Ruether; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Susan L Cotman
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

9.  Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender.

Authors:  Attila D Kovács; David A Pearce
Journal:  Dis Model Mech       Date:  2015-04       Impact factor: 5.758

Review 10.  Cellular models of Batten disease.

Authors:  Christopher J Minnis; Christopher D Thornton; Lorna M FitzPatrick; Tristan R McKay
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-10-23       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.